from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0021c/-

LFCtreatmentdescriptionclass of inhibitor

0.210

Amikacinug/mL Amikacintranslation

0.507

Cap5-10ug/mL Capreomycintranslation

1.285

Rox10-50 ug/mL Roxithromycintranslation

-0.341

SM2-5 ug/mL Streptomycintranslation

-0.382

Tet5-10 ug/mL Tetracyclinetranslation

0.529

Rif0.2-5ug/mL Rifampicintranscription

0.069

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.005

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.867

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.118

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.534

Clofazimine10-13 ug/mL Clofaziminerespiration

0.692

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.024

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.363

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.459

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.415

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.194

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.173

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.321

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.113

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.730

KCN5-20 ug/mL Potassium cyaniderespiration

-0.425

NaN30.2-2 mM Sodium aziderespiration

1.221

Nigericin50 uM Nigericinrespiration

-0.833

TRC10-150 ug/mL Triclosanrespiration

-1.323

TRZ10-25 ug/mL Thioridazinerespiration

-1.231

Valinomycin0.5-10 uM Valinomycinrespiration

1.783

ZnSO42 mM ZnSO4respiration

-0.398

menadione6-10 ug/mL Menadionerespiration

0.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.655

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.329

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.144

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.836

NRP_1Non-replicating persistence stage 1dosRassociated

0.007

Amp0.2mg/mL AmpicillincellWall

0.249

Cephalexin20-100 ug/mL CephalexincellWall

0.632

Cerulenin0.32-5 ug/mL CerulenincellWall

0.533

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.099

EMB10-20 ug/mL EthambutolcellWall

0.252

Eta12-40 ug/mL EthionamidecellWall

0.508

INH0.2-0.4 ug/mL IsoniazidcellWall

0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.186

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.079

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.344

BZA0.12 mg/mL BenzamidearomaticAmides

-0.410

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.529

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.553

H2O24 mM hydrogen peroxideDNAdamaging

-0.024

Levo10 ug/mL LevofloxacinDNAdamaging

0.057

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.258

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.274

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.024

UVUV-irradiationDNAdamaging

-0.214

ARP41-4 ug/mL Antitubercular compound ARP4?

0.245

Antimycin12.5-50 ug/mL Antimycin A?

0.603

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.306

PA_110-50 ug/mL Antitubercular compound PA-1?

0.309

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.960

PA8240.2-2 ug/mL PA-824?

-0.907

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.434

Verapamil50 uM Verapamil?

0.005

mercaptoethanol2 mM 2-Mercaptoethanol?

0.999

methoxatin10-20 ug/mL Methoxatin?